Figure 2 of Fautsch, Mol Vis 2004; 10:417-425.


Figure 2. Oligonucleotides used to create myocilin constructs

Oligonucleotide sequence, specific nucleotide location, oligonucleotides used to amplify 5' and 3' intermediate PCR fragments, and fragment lengths are listed for templates used. Highlighted base pairs represent alanine codon substitution. Asterisks indicate complementary strand. A: In vitro studies. B: In vivo studies.

A:

Construct    Oligo
  name       name                       Sequence                    Nucleotide
---------   -------   -------------------------------------------   ----------
   C1       Cy1-5al   5'-AGAGTGGCCGAGCCCAGTATACCTTCAGTG-3'           164- 193
            Cy1-3al   5'-AGGTATACTGGGCTCGGCCACTCTGGTCATTG-3'         156- 187*

   C2       Cy2-5al   5'-GAATCCAGCGCCCCAGAGCAGAGCCAGGCCATG-3'        208- 240
            Cy2-3al   5'-GCTCTGCTCTGGGGCGCTGGATTCATTGGGACTG-3'       198- 226*

   C3       Cy3-5al   5'-AGGGGCCAGGCTCCCCAGACCCGAGACACTG-3'          580- 610
            Cy3-3al   5'-TCTGGGGAGCCTGGCCCCTTCTCAGCCTTGC-3'          568- 598*

   C4       Cy4-5al   5'-ACACCGGAGCTGGAGAACTAGTTTGGGTAG-3'           761- 790
            Cy4-3al   5'-CTAGTTCTCCAGCTCCGGTGTCTCCCTCTCCAC-3'        749- 781*

   C5       Cy5-5al   5'-TTCATCATCGCTGGCACCTTGTACACCGTCAGC-3'       1324-1359
            Cy5-3al   5'-CAAGGTGCCAGCGATGATGAAGGCATTGGCGAC-3'       1312-1344*

            MYOC-5'   5'-ATGCGAATTCAGGACAGCTCAGCTCAGGAAGGC-3'       133- 155
            MYOC-3'   5'-ATGCGGATCCTTATCACATCTTGGAGAGCTTGATGTC-3'   1528-1551*


Construct   Intermediate                           Amplified    Fragment
  name      PCR product    Oligonucleotide pair   nucleotides    length
---------   ------------   --------------------   -----------   --------
   C1       5' fragment      MYOC-5', Cy1-3al       133- 187        55
            3' fragment      MYOC-3', Cy1-5al       164-1551      1388

   C2       5' fragment      MYOC-5', Cy2-3al       133- 226        94
            3' fragment      MYOC-3', Cy2-5al       208-1551      1344

   C3       5' fragment      MYOC-5', Cy3-3al       133- 598       466
            3' fragment      MYOC-3', Cy3-5al       580-1551       972

   C4       5' fragment      MYOC-5', Cy4-3al       133- 781       649
            3' fragment      MYOC-3', Cy4-5al       761-1551       791

   C5       5' fragment      MYOC-5', Cy5-3al       133-1344      1212
            3' fragment      MYOC-3', Cy5-5al      1359-1551       193

B:

Construct     Oligo
  name        name                        Sequence                     Nucleotide
---------   ---------   --------------------------------------------   ----------
Arg82Cys    Arg5-3cy    5'-AGCAGCACCCAATGCTTAGACCTGGAGGCCAC-3'          268- 299
            Arg3-5cy    5'-CTCCAGGTCTAAGCATTGGGTGCTGCTGTCTC-3'          263- 293*

Cys433Arg   Cys433-5'   5'-GCCTTCATCATCCGTGGCACCTTGTACACCGTCAGC-3'     1321-1356
            Cys433-3'   5'-GGTGCCACGGATGATGAAGGCATTGGCGAC-3'           1312-1341*

            MYOC5-H3    5'-TAGCGAAGCTTTCTGCAATGAGGTTCTTCTGTGC-3'         31-  53
            MYOC-Stop   5'-ATGCGTCTAGATCATCACATCTTGGAGAGCTTGATGTC-3'   1528-1551*


Construct   Intermediate                           Amplified    Fragment
  name      PCR product    Oligonucleotide pair   nucleotides    length
---------   ------------   --------------------   -----------   --------
Arg82Cys    5' fragment    MYOC5-H3, Arg3-5cy        31- 293       263
            3' fragment    MYOC-Stop, Arg5-3cy      268-1551      1284

Cys433Arg   5' fragment    MYOC5-H3, Cys433-3'       31-1341      1311
            3' fragment    MYOC-Stop, Cys433-5'    1321-1551       231

Fautsch, Mol Vis 2004; 10:417-425 <http://www.molvis.org/molvis/v10/a52/>
©2004 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535